Dividends & Income
To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
I am now retired from the US pharma industry having spent over 33 years in the Mid-Atlantic corridor in Sales(Hospital mainly), Scientific Relations and Managed Care/LTC. I worked at BMY, Bayer/Miles Labs and SGP/MRK prior to early retirement..
Today I enjoy investing in Bio-Pharmas mostly, because it is what I know best!
I invest mostly in large companies such as BMY, PFE, MRK, GSK, and JNJ (love the divis) but I like the up and coming Bios like CLDX. Cancer and Immunotherapy intrigues me..so I have made that a major consideration since 2008....With the GAIN act and QDIP Ive come to appreciate the Antibiotic cos.and have made them a major component of my LT strategy to build wealth while in
Retirement....Trius(TSRX) was my first endeavor and now Ive branched out into others...including CBST, CEMP, DRTX, TTPH and most recently a little known pink otc called CTIX.....
Dividend stock ideas & income, Gold, Retirement savings, Stocks - long, Stocks - short, Tech stocks
Currently, there is no company profile for retiredpharma.
Currently, there are no blog details for retiredpharma.
Currently, there are no book details for retiredpharma.
Vuru,Ive owned BMY over the...
Bristol-Myers Squibb's Opdivo Breezes Through F...
12120341,The 6 month read i...
A Look At Afrezza Prescriptions Through Week 6 ...
ADRI-72,Olson can read Reut...
A Close-Up Look At The Report That Had MannKind...
Carly,If I listened to ANAL...
Analysts Weigh In On MannKind Following Q4 Results
Dave,Your article appears t...
PDL BioPharma: Beware The 8% Dividend
Xignite quote data
© 2015 Seeking Alpha